Global Immunoprecipitation Market By Offering (Kits, Reagents – Antibodies: Primary, Secondary, Beads – Agarose, Magnetic, Others); By Type (Chromatin, Protein Complex, Individual protein, RNA (ribonucleoproteins), Co-Immunoprecipitation (Co-IP), Tagged Protein IP; By Distribution Channel (Online, Offline); By End Use (Academic & Research Institutes, Pharmaceutical companies, Contact Research Organization); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In terms of revenue, the global immunoprecipitation market was valued at US$ 923.6 Mn in 2021, growing at an estimated CAGR of 6% over the forecast period. Protein is the basic building block for the human body and plays vital role in enhancing one’s immunity. Greater immunity means better capability of human body to fight a virus or disease. Antibodies happen to be those cells in the human body that battle against any infection or ailment. Several techniques or methods Immunoprecipitation (IP) happens to be process of purification of antigens at a small scale with the help of a specific antibody that is immobilized to a solid support just like magnetic particles or agarose resin. This process of Immunoprecipitation is primarily used for isolation of proteins along with other biomolecules from cell or tissue lysates in order to detect through western blotting and other assay techniques. The main objective of immunoprecipitation completely depends on the recognition of a target protein antigen through a specific antibody. The global immunoprecipitation market is rapidly owing in wake of various factors.
The global immunoprecipitation market emerged incredibly profitable during the coronavirus pandemic. The highly contagious virus blatantly attacked the respiratory systems of those with weaker immunity. Stronger and better antibodies were needed to battle the SARS-CoV-2 virus and this helped the market grow.
Offering Outlook
On the basis of offering, the global immunoprecipitation market has been divided into kits, and reagents. The reagents segment is further bifurcated into antibodies and beads, and these two categories are further categorised into primary and secondary, and agarose and magnetic respectively. The reagents segment accounts for majority of revenue generated by this market. On the other hand, the kits segment is expected to see growth at the fastest rate.
Global Immunoprecipitation Market Revenue & Forecast, (US$ Million), 2022 – 2030
Type Outlook
On the basis of type, the global immunoprecipitation market has been categorised into chromatin, protein complex, individual protein, RNA (ribonucleoproteins), co-immonoprecipitation (Co-Ip) and tagged protein IP. The individual protein segment generates major chunk of revenue for this market. Proteins are produced from hundreds or thousands of smaller units that are called amino acids, and happen to be attached to each other in long chains.
Distribution Channel Outlook
The distribution channel segment of the global immunoprecipitation market has been divided into online and offline. The offline segment has been dominating majorly as those companies’ trading reagents and kits are working offline. Though the online segment is likely to grow rampantly.
End Use Outlook
The end use segment of the global immunoprecipitation market has been bifurcated into academic & research institutes, pharmaceutical companies and contact research organization. The academic & research institutes segment hold major market share and this is because research is continuous process. Due to increasing investments in the field of medical research, the academic & research institutes segment is growing.
Region Outlook
On the basis of region, the global immunoprecipitation market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America has been generating majority of revenue for the major amount of the sales for this market. Presence of top companies in the pharmaceutical companies along with leading research institutes in nations like the United States and Canada.
Competitive Landscape
The report provides both, qualitative and quantitative research of the global immunoprecipitation market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
A few of the major players operating in the global immunoprecipitation market are listed below:
- Abbexa
- Abbkine, Inc.
- Abcam plc.
- Aves Labs
- BioLegend, Inc.
- Bio-Rad Laboratories, Inc.
- BioVision Inc.
- Geno Technology Inc
- GenScript
- Merck KGaA
- Santa Cruz Biotechnology, Inc.
- Takara Bio Inc.
- Thermo Fisher Scientific
- VWR International, LLC
- Other Market Participants
Global Immunoprecipitation Market
By Offering
- Kits
- Reagents
- Antibodies
- Primary
- Secondary
- Beads
- Agarose
- Magnetic
- Others
- Antibodies
By Type
- Chromatin
- Protein Complex
- Individual protein
- RNA (robonucleoproteins)
- Co-Immunoprecipitation (Co-IP)
- Tagged Protein IP
By Distribution Channel
- Online
- Offline
By End Use
- Academic & Research Institutes
- Pharmaceutical companies
- Contact Research Organization
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Immunoprecipitation Market
6.
Market
Synopsis: Immunoprecipitation Market
7.
Immunoprecipitation Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Immunoprecipitation Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Immunoprecipitation Market
7.6. Impact of Covid-19 on
Immunoprecipitation Market
8.
Global
Immunoprecipitation Market Analysis and
Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Immunoprecipitation Market Revenue (US$ Mn)
8.2. Global Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Offering
8.2.1. Kits
8.2.1.1.
Definition
8.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market
Forecast, 2022 – 2030
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Reagents
(Definition, Market Estimation and Penetration, 2015 - 2021, Market
Estimation (2015 - 2021), Market Forecast ( 2022 – 2030), Compound Annual
Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific,
Middle East and Africa, Latin America) and Information on Antibodies , Beads ,
Others)
8.2.2.1.
Antibodies
8.2.2.1.1.
Primary
8.2.2.1.2.
Secondary
8.2.2.2.
Beads
8.2.2.2.1.
Agarose
8.2.2.2.2.
Magnetic
8.2.2.3.
Others
8.3. Key Segment for Channeling Investments
8.3.1. By Offering
9.
Global
Immunoprecipitation Market Analysis and
Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Type
9.2.1. Chromatin
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Protein Complex
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Individual protein
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 – 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. RNA (ribonucleoproteins)
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 – 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.2.5. Co-Immunoprecipitation (Co-IP)
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market
Forecast, 2022 – 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 – 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 – 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 – 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 – 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 – 2030
9.2.6. Tagged Protein IP
9.2.6.1.
Definition
9.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.6.3.
Market
Forecast, 2022 – 2030
9.2.6.4.
Compound
Annual Growth Rate (CAGR)
9.2.6.5.
Regional
Bifurcation
9.2.6.5.1.
North
America
9.2.6.5.1.1. Market Estimation, 2015 - 2021
9.2.6.5.1.2. Market Forecast, 2022 – 2030
9.2.6.5.2.
Europe
9.2.6.5.2.1. Market Estimation, 2015 - 2021
9.2.6.5.2.2. Market Forecast, 2022 – 2030
9.2.6.5.3.
Asia
Pacific
9.2.6.5.3.1. Market Estimation, 2015 - 2021
9.2.6.5.3.2. Market Forecast, 2022 – 2030
9.2.6.5.4.
Middle
East and Africa
9.2.6.5.4.1. Market Estimation, 2015 - 2021
9.2.6.5.4.2. Market Forecast, 2022 – 2030
9.2.6.5.5.
Latin
America
9.2.6.5.5.1. Market Estimation, 2015 - 2021
9.2.6.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Type
10. Global Immunoprecipitation Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Immunoprecipitation Market Revenue (US$ Mn) and Forecasts,
By Distribution channel
10.2.1. Online
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 – 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Offline
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 – 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By
Distribution channel
11. Global Immunoprecipitation Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By End
Use
11.2.1. Research Institutes
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 – 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North
America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3.
Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Pharmaceutical companies
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 – 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4.
Middle
East and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Contact Research Organization
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 – 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End Use
12. North America Immunoprecipitation Market Analysis and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Immunoprecipitation Market Revenue (US$ Mn)
12.2. North America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Offering
12.2.1. Kits
12.2.2. Reagents
12.2.2.1.
Antibodies
12.2.2.1.1.
Primary
12.2.2.1.2.
Secondary
12.2.2.2.
Beads
12.2.2.2.1.
Agarose
12.2.2.2.2.
Magnetic
12.2.2.3.
Others
12.3. North America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Type
12.3.1. Chromatin
12.3.2. Protein Complex
12.3.3. Individual protein
12.3.4. RNA (ribonucleoproteins)
12.3.5. Co-Immunoprecipitation (Co-IP)
12.3.6. Tagged Protein IP
12.4. North America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts,
By Distribution channel
12.4.1. Online
12.4.2. Offline
12.5. North America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By End
Use
12.5.1. Research Institutes
12.5.2. Pharmaceutical companies
12.5.3. Contact Research Organization
12.6. North America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Country
12.6.1. U.S
12.6.1.1.
U.S
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.1.1.1.
Kits
12.6.1.1.2.
Reagents
12.6.1.1.2.1. Antibodies
12.6.1.1.2.1.1. Primary
12.6.1.1.2.1.2. Secondary
12.6.1.1.2.2. Beads
12.6.1.1.2.2.1. Agarose
12.6.1.1.2.2.2. Magnetic
12.6.1.1.2.3. Others
12.6.1.2.
U.S
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
12.6.1.2.1.
Chromatin
12.6.1.2.2.
Protein
Complex
12.6.1.2.3.
Individual
protein
12.6.1.2.4.
RNA
(ribonucleoproteins)
12.6.1.2.5.
Co-Immunoprecipitation
(Co-IP)
12.6.1.2.6.
Tagged
Protein IP
12.6.1.3.
U.S
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
12.6.1.3.1.
Online
12.6.1.3.2.
Offline
12.6.1.4.
U.S
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
12.6.1.4.1.
Research
Institutes
12.6.1.4.2.
Pharmaceutical
companies
12.6.1.4.3.
Contact
Research Organization
12.6.2. Canada
12.6.2.1.
Canada
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.2.1.1.
Kits
12.6.2.1.2.
Reagents
12.6.2.1.2.1. Antibodies
12.6.2.1.2.1.1. Primary
12.6.2.1.2.1.2. Secondary
12.6.2.1.2.2. Beads
12.6.2.1.2.2.1. Agarose
12.6.2.1.2.2.2. Magnetic
12.6.2.1.2.3. Others
12.6.2.2.
Canada
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
12.6.2.2.1.
Chromatin
12.6.2.2.2.
Protein
Complex
12.6.2.2.3.
Individual
protein
12.6.2.2.4.
RNA
(ribonucleoproteins)
12.6.2.2.5.
Co-Immunoprecipitation
(Co-IP)
12.6.2.2.6.
Tagged
Protein IP
12.6.2.3.
Canada
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
12.6.2.3.1.
Online
12.6.2.3.2.
Offline
12.6.2.4.
Canada
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
12.6.2.4.1.
Research
Institutes
12.6.2.4.2.
Pharmaceutical
companies
12.6.2.4.3.
Contact
Research Organization
12.6.3. Mexico
12.6.3.1.
Mexico
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
12.6.3.1.1.
Kits
12.6.3.1.2.
Reagents
12.6.3.1.2.1. Antibodies
12.6.3.1.2.1.1. Primary
12.6.3.1.2.1.2. Secondary
12.6.3.1.2.2. Beads
12.6.3.1.2.2.1. Agarose
12.6.3.1.2.2.2. Magnetic
12.6.3.1.2.3. Others
12.6.3.2.
Mexico
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
12.6.3.2.1.
Chromatin
12.6.3.2.2.
Protein
Complex
12.6.3.2.3.
Individual
protein
12.6.3.2.4.
RNA
(ribonucleoproteins)
12.6.3.2.5.
Co-Immunoprecipitation
(Co-IP)
12.6.3.2.6.
Tagged
Protein IP
12.6.3.3.
Mexico
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
12.6.3.3.1.
Online
12.6.3.3.2.
Offline
12.6.3.4.
Mexico
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
12.6.3.4.1.
Research
Institutes
12.6.3.4.2.
Pharmaceutical
companies
12.6.3.4.3.
Contact
Research Organization
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
12.6.4.1.1.
Kits
12.6.4.1.2.
Reagents
12.6.4.1.2.1. Antibodies
12.6.4.1.2.1.1. Primary
12.6.4.1.2.1.2. Secondary
12.6.4.1.2.2. Beads
12.6.4.1.2.2.1. Agarose
12.6.4.1.2.2.2. Magnetic
12.6.4.1.2.3. Others
12.6.4.2.
Rest of
North America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
12.6.4.2.1.
Chromatin
12.6.4.2.2.
Protein
Complex
12.6.4.2.3.
Individual
protein
12.6.4.2.4.
RNA
(ribonucleoproteins)
12.6.4.2.5.
Co-Immunoprecipitation
(Co-IP)
12.6.4.2.6.
Tagged
Protein IP
12.6.4.3.
Rest of
North America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
12.6.4.3.1.
Online
12.6.4.3.2.
Offline
12.6.4.4.
Rest of
North America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
12.6.4.4.1.
Research
Institutes
12.6.4.4.2.
Pharmaceutical
companies
12.6.4.4.3.
Contact
Research Organization
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Offering
12.7.3. By Type
12.7.4. By
Distribution channel
12.7.5. By End Use
13. Europe Immunoprecipitation Market Analysis and Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Immunoprecipitation Market Revenue (US$ Mn)
13.2. Europe Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Offering
13.2.1. Kits
13.2.2. Reagents
13.2.2.1.
Antibodies
13.2.2.1.1.
Primary
13.2.2.1.2.
Secondary
13.2.2.2.
Beads
13.2.2.2.1.
Agarose
13.2.2.2.2.
Magnetic
13.2.2.3.
Others
13.3. Europe Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Type
13.3.1. Chromatin
13.3.2. Protein Complex
13.3.3. Individual protein
13.3.4. RNA (ribonucleoproteins)
13.3.5. Co-Immunoprecipitation (Co-IP)
13.3.6. Tagged Protein IP
13.4. Europe Immunoprecipitation Market Revenue (US$ Mn) and Forecasts,
By Distribution channel
13.4.1. Online
13.4.2. Offline
13.5. Europe Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By End
Use
13.5.1. Research Institutes
13.5.2. Pharmaceutical companies
13.5.3. Contact Research Organization
13.6. Europe Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Country
13.6.1. France
13.6.1.1.
France
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.1.1.1.
Kits
13.6.1.1.2.
Reagents
13.6.1.1.2.1. Antibodies
13.6.1.1.2.1.1. Primary
13.6.1.1.2.1.2. Secondary
13.6.1.1.2.2. Beads
13.6.1.1.2.2.1. Agarose
13.6.1.1.2.2.2. Magnetic
13.6.1.1.2.3. Others
13.6.1.2.
France
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
13.6.1.2.1.
Chromatin
13.6.1.2.2.
Protein
Complex
13.6.1.2.3.
Individual
protein
13.6.1.2.4.
RNA
(ribonucleoproteins)
13.6.1.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.1.2.6.
Tagged
Protein IP
13.6.1.3.
France
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
13.6.1.3.1.
Online
13.6.1.3.2.
Offline
13.6.1.4.
France
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.1.4.1.
Research
Institutes
13.6.1.4.2.
Pharmaceutical
companies
13.6.1.4.3.
Contact
Research Organization
13.6.2. The UK
13.6.2.1.
The UK
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.2.1.1.
Kits
13.6.2.1.2.
Reagents
13.6.2.1.2.1. Antibodies
13.6.2.1.2.1.1. Primary
13.6.2.1.2.1.2. Secondary
13.6.2.1.2.2. Beads
13.6.2.1.2.2.1. Agarose
13.6.2.1.2.2.2. Magnetic
13.6.2.1.2.3. Others
13.6.2.2.
The UK
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
13.6.2.2.1.
Chromatin
13.6.2.2.2.
Protein
Complex
13.6.2.2.3.
Individual
protein
13.6.2.2.4.
RNA (ribonucleoproteins)
13.6.2.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.2.2.6.
Tagged
Protein IP
13.6.2.3.
The UK
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
13.6.2.3.1.
Online
13.6.2.3.2.
Offline
13.6.2.4.
The UK
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.2.4.1.
Research
Institutes
13.6.2.4.2.
Pharmaceutical
companies
13.6.2.4.3.
Contact
Research Organization
13.6.3. Spain
13.6.3.1.
Spain
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.3.1.1.
Kits
13.6.3.1.2.
Reagents
13.6.3.1.2.1. Antibodies
13.6.3.1.2.1.1. Primary
13.6.3.1.2.1.2. Secondary
13.6.3.1.2.2. Beads
13.6.3.1.2.2.1. Agarose
13.6.3.1.2.2.2. Magnetic
13.6.3.1.2.3. Others
13.6.3.2.
Spain
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
13.6.3.2.1.
Chromatin
13.6.3.2.2.
Protein
Complex
13.6.3.2.3.
Individual
protein
13.6.3.2.4.
RNA
(ribonucleoproteins)
13.6.3.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.3.2.6.
Tagged
Protein IP
13.6.3.3.
Spain
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
13.6.3.3.1.
Online
13.6.3.3.2.
Offline
13.6.3.4.
Spain
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.3.4.1.
Research
Institutes
13.6.3.4.2.
Pharmaceutical
companies
13.6.3.4.3.
Contact
Research Organization
13.6.4. Germany
13.6.4.1.
Germany
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.4.1.1.
Kits
13.6.4.1.2.
Reagents
13.6.4.1.2.1. Antibodies
13.6.4.1.2.1.1. Primary
13.6.4.1.2.1.2. Secondary
13.6.4.1.2.2. Beads
13.6.4.1.2.2.1. Agarose
13.6.4.1.2.2.2. Magnetic
13.6.4.1.2.3. Others
13.6.4.2.
Germany
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
13.6.4.2.1.
Chromatin
13.6.4.2.2.
Protein
Complex
13.6.4.2.3.
Individual
protein
13.6.4.2.4.
RNA
(ribonucleoproteins)
13.6.4.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.4.2.6.
Tagged
Protein IP
13.6.4.3.
Germany
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
13.6.4.3.1.
Online
13.6.4.3.2.
Offline
13.6.4.4.
Germany Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By End
Use
13.6.4.4.1.
Research
Institutes
13.6.4.4.2.
Pharmaceutical
companies
13.6.4.4.3.
Contact
Research Organization
13.6.5. Italy
13.6.5.1.
Italy
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
13.6.5.1.1.
Kits
13.6.5.1.2.
Reagents
13.6.5.1.2.1. Antibodies
13.6.5.1.2.1.1. Primary
13.6.5.1.2.1.2. Secondary
13.6.5.1.2.2. Beads
13.6.5.1.2.2.1. Agarose
13.6.5.1.2.2.2. Magnetic
13.6.5.1.2.3. Others
13.6.5.2.
Italy
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
13.6.5.2.1.
Chromatin
13.6.5.2.2.
Protein
Complex
13.6.5.2.3.
Individual
protein
13.6.5.2.4.
RNA
(ribonucleoproteins)
13.6.5.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.5.2.6.
Tagged
Protein IP
13.6.5.3.
Italy
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
13.6.5.3.1.
Online
13.6.5.3.2.
Offline
13.6.5.4.
Italy
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
13.6.5.4.1.
Research
Institutes
13.6.5.4.2.
Pharmaceutical
companies
13.6.5.4.3.
Contact
Research Organization
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
13.6.6.1.1.
Kits
13.6.6.1.2.
Reagents
13.6.6.1.2.1. Antibodies
13.6.6.1.2.1.1. Primary
13.6.6.1.2.1.2. Secondary
13.6.6.1.2.2. Beads
13.6.6.1.2.2.1. Agarose
13.6.6.1.2.2.2. Magnetic
13.6.6.1.2.3. Others
13.6.6.2.
Nordic
Countries Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
13.6.6.2.1.
Chromatin
13.6.6.2.2.
Protein
Complex
13.6.6.2.3.
Individual
protein
13.6.6.2.4.
RNA
(ribonucleoproteins)
13.6.6.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.6.2.6.
Tagged
Protein IP
13.6.6.3.
Nordic
Countries Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
13.6.6.3.1.
Online
13.6.6.3.2.
Offline
13.6.6.4.
Nordic
Countries Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
13.6.6.4.1.
Research
Institutes
13.6.6.4.2.
Pharmaceutical
companies
13.6.6.4.3.
Contact
Research Organization
13.6.6.5.
Nordic
Countries Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Offering
13.6.7.1.1.
Kits
13.6.7.1.2.
Reagents
13.6.7.1.2.1. Antibodies
13.6.7.1.2.1.1. Primary
13.6.7.1.2.1.2. Secondary
13.6.7.1.2.2. Beads
13.6.7.1.2.2.1. Agarose
13.6.7.1.2.2.2. Magnetic
13.6.7.1.2.3. Others
13.6.7.2.
Benelux
Union Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Type
13.6.7.2.1.
Chromatin
13.6.7.2.2.
Protein
Complex
13.6.7.2.3.
Individual
protein
13.6.7.2.4.
RNA
(ribonucleoproteins)
13.6.7.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.7.2.6.
Tagged
Protein IP
13.6.7.3.
Benelux
Union Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Distribution
channel
13.6.7.3.1.
Online
13.6.7.3.2.
Offline
13.6.7.4.
Benelux
Union Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By End Use
13.6.7.4.1.
Research
Institutes
13.6.7.4.2.
Pharmaceutical
companies
13.6.7.4.3.
Contact
Research Organization
13.6.7.5.
Benelux
Union Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
13.6.8.1.1.
Kits
13.6.8.1.2.
Reagents
13.6.8.1.2.1. Antibodies
13.6.8.1.2.1.1. Primary
13.6.8.1.2.1.2. Secondary
13.6.8.1.2.2. Beads
13.6.8.1.2.2.1. Agarose
13.6.8.1.2.2.2. Magnetic
13.6.8.1.2.3. Others
13.6.8.2.
Rest of
Europe Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
13.6.8.2.1.
Chromatin
13.6.8.2.2.
Protein
Complex
13.6.8.2.3.
Individual
protein
13.6.8.2.4.
RNA
(ribonucleoproteins)
13.6.8.2.5.
Co-Immunoprecipitation
(Co-IP)
13.6.8.2.6.
Tagged
Protein IP
13.6.8.3.
Rest of
Europe Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
13.6.8.3.1.
Online
13.6.8.3.2.
Offline
13.6.8.4.
Rest of
Europe Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
13.6.8.4.1.
Research
Institutes
13.6.8.4.2.
Pharmaceutical
companies
13.6.8.4.3.
Contact
Research Organization
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Offering
13.7.3. By Type
13.7.4. By
Distribution channel
13.7.5. By End Use
14. Asia Pacific Immunoprecipitation Market Analysis and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Immunoprecipitation Market Revenue (US$ Mn)
14.2. Asia Pacific Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Offering
14.2.1. Kits
14.2.2. Reagents
14.2.2.1.
Antibodies
14.2.2.1.1.
Primary
14.2.2.1.2.
Secondary
14.2.2.2.
Beads
14.2.2.2.1.
Agarose
14.2.2.2.2.
Magnetic
14.2.2.3.
Others
14.3. Asia Pacific Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Type
14.3.1. Chromatin
14.3.2. Protein Complex
14.3.3. Individual protein
14.3.4. RNA (ribonucleoproteins)
14.3.5. Co-Immunoprecipitation (Co-IP)
14.3.6. Tagged Protein IP
14.4. Asia Pacific Immunoprecipitation Market Revenue (US$ Mn) and Forecasts,
By Distribution channel
14.4.1. Online
14.4.2. Offline
14.5. Asia Pacific Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By End
Use
14.5.1. Research Institutes
14.5.2. Pharmaceutical companies
14.5.3. Contact Research Organization
14.6. Asia Pacific Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Country
14.6.1. China
14.6.1.1.
China
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.1.1.1.
Kits
14.6.1.1.2.
Reagents
14.6.1.1.2.1. Antibodies
14.6.1.1.2.1.1. Primary
14.6.1.1.2.1.2. Secondary
14.6.1.1.2.2. Beads
14.6.1.1.2.2.1. Agarose
14.6.1.1.2.2.2. Magnetic
14.6.1.1.2.3. Others
14.6.1.2.
China
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
14.6.1.2.1.
Chromatin
14.6.1.2.2.
Protein
Complex
14.6.1.2.3.
Individual
protein
14.6.1.2.4.
RNA
(ribonucleoproteins)
14.6.1.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.1.2.6.
Tagged
Protein IP
14.6.1.3.
China
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
14.6.1.3.1.
Online
14.6.1.3.2.
Offline
14.6.1.4.
China
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.1.4.1.
Research
Institutes
14.6.1.4.2.
Pharmaceutical
companies
14.6.1.4.3.
Contact
Research Organization
14.6.2. Japan
14.6.2.1.
Japan
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.2.1.1.
Kits
14.6.2.1.2.
Reagents
14.6.2.1.2.1. Antibodies
14.6.2.1.2.1.1. Primary
14.6.2.1.2.1.2. Secondary
14.6.2.1.2.2. Beads
14.6.2.1.2.2.1. Agarose
14.6.2.1.2.2.2. Magnetic
14.6.2.1.2.3. Others
14.6.2.2.
Japan
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
14.6.2.2.1.
Chromatin
14.6.2.2.2.
Protein
Complex
14.6.2.2.3.
Individual
protein
14.6.2.2.4.
RNA
(ribonucleoproteins)
14.6.2.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.2.2.6.
Tagged
Protein IP
14.6.2.3.
Japan
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
14.6.2.3.1.
Online
14.6.2.3.2.
Offline
14.6.2.4.
Japan
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.2.4.1.
Research
Institutes
14.6.2.4.2.
Pharmaceutical
companies
14.6.2.4.3.
Contact
Research Organization
14.6.3. India
14.6.3.1.
India
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.3.1.1.
Kits
14.6.3.1.2.
Reagents
14.6.3.1.2.1. Antibodies
14.6.3.1.2.1.1. Primary
14.6.3.1.2.1.2. Secondary
14.6.3.1.2.2. Beads
14.6.3.1.2.2.1. Agarose
14.6.3.1.2.2.2. Magnetic
14.6.3.1.2.3. Others
14.6.3.2.
India
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
14.6.3.2.1.
Chromatin
14.6.3.2.2.
Protein
Complex
14.6.3.2.3.
Individual
protein
14.6.3.2.4.
RNA
(ribonucleoproteins)
14.6.3.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.3.2.6.
Tagged
Protein IP
14.6.3.3.
India
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
14.6.3.3.1.
Online
14.6.3.3.2.
Offline
14.6.3.4.
India
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.3.4.1.
Research
Institutes
14.6.3.4.2.
Pharmaceutical
companies
14.6.3.4.3.
Contact
Research Organization
14.6.4. New Zealand
14.6.4.1.
New Zealand
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.4.1.1.
Kits
14.6.4.1.2.
Reagents
14.6.4.1.2.1. Antibodies
14.6.4.1.2.1.1. Primary
14.6.4.1.2.1.2. Secondary
14.6.4.1.2.2. Beads
14.6.4.1.2.2.1. Agarose
14.6.4.1.2.2.2. Magnetic
14.6.4.1.2.3. Others
14.6.4.2.
New
Zealand Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
14.6.4.2.1.
Chromatin
14.6.4.2.2.
Protein
Complex
14.6.4.2.3.
Individual
protein
14.6.4.2.4.
RNA
(ribonucleoproteins)
14.6.4.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.4.2.6.
Tagged
Protein IP
14.6.4.3.
New
Zealand Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
14.6.4.3.1.
Online
14.6.4.3.2.
Offline
14.6.4.4.
New
Zealand Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
14.6.4.4.1.
Research
Institutes
14.6.4.4.2.
Pharmaceutical
companies
14.6.4.4.3.
Contact
Research Organization
14.6.5. Australia
14.6.5.1.
Australia
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
14.6.5.1.1.
Kits
14.6.5.1.2.
Reagents
14.6.5.1.2.1. Antibodies
14.6.5.1.2.1.1. Primary
14.6.5.1.2.1.2. Secondary
14.6.5.1.2.2. Beads
14.6.5.1.2.2.1. Agarose
14.6.5.1.2.2.2. Magnetic
14.6.5.1.2.3. Others
14.6.5.2.
Australia
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
14.6.5.2.1.
Chromatin
14.6.5.2.2.
Protein
Complex
14.6.5.2.3.
Individual
protein
14.6.5.2.4.
RNA
(ribonucleoproteins)
14.6.5.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.5.2.6.
Tagged
Protein IP
14.6.5.3.
Australia
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
14.6.5.3.1.
Online
14.6.5.3.2.
Offline
14.6.5.4.
Australia
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
14.6.5.4.1.
Research
Institutes
14.6.5.4.2.
Pharmaceutical
companies
14.6.5.4.3.
Contact
Research Organization
14.6.6. South Korea
14.6.6.1.
South
Korea Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.6.1.1.
Kits
14.6.6.1.2.
Reagents
14.6.6.1.2.1. Antibodies
14.6.6.1.2.1.1. Primary
14.6.6.1.2.1.2. Secondary
14.6.6.1.2.2. Beads
14.6.6.1.2.2.1. Agarose
14.6.6.1.2.2.2. Magnetic
14.6.6.1.2.3. Others
14.6.6.2.
South
Korea Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.6.2.1.
Chromatin
14.6.6.2.2.
Protein
Complex
14.6.6.2.3.
Individual
protein
14.6.6.2.4.
RNA
(ribonucleoproteins)
14.6.6.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.6.2.6.
Tagged
Protein IP
14.6.6.3.
South
Korea Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Distribution
channel
14.6.6.3.1.
Online
14.6.6.3.2.
Offline
14.6.6.4.
South
Korea Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By End Use
14.6.6.4.1.
Research
Institutes
14.6.6.4.2.
Pharmaceutical
companies
14.6.6.4.3.
Contact
Research Organization
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Offering
14.6.7.1.1.
Kits
14.6.7.1.2.
Reagents
14.6.7.1.2.1. Antibodies
14.6.7.1.2.1.1. Primary
14.6.7.1.2.1.2. Secondary
14.6.7.1.2.2. Beads
14.6.7.1.2.2.1. Agarose
14.6.7.1.2.2.2. Magnetic
14.6.7.1.2.3. Others
14.6.7.2.
Southeast
Asia Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Type
14.6.7.2.1.
Chromatin
14.6.7.2.2.
Protein
Complex
14.6.7.2.3.
Individual
protein
14.6.7.2.4.
RNA
(ribonucleoproteins)
14.6.7.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.7.2.6.
Tagged
Protein IP
14.6.7.3.
Southeast
Asia Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Distribution
channel
14.6.7.3.1.
Online
14.6.7.3.2.
Offline
14.6.7.4.
Southeast
Asia Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By End Use
14.6.7.4.1.
Research
Institutes
14.6.7.4.2.
Pharmaceutical
companies
14.6.7.4.3.
Contact
Research Organization
14.6.7.5.
Southeast
Asia Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
14.6.8.1.1.
Kits
14.6.8.1.2.
Reagents
14.6.8.1.2.1. Antibodies
14.6.8.1.2.1.1. Primary
14.6.8.1.2.1.2. Secondary
14.6.8.1.2.2. Beads
14.6.8.1.2.2.1. Agarose
14.6.8.1.2.2.2. Magnetic
14.6.8.1.2.3. Others
14.6.8.2.
Rest of
Asia Pacific Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
14.6.8.2.1.
Chromatin
14.6.8.2.2.
Protein
Complex
14.6.8.2.3.
Individual
protein
14.6.8.2.4.
RNA
(ribonucleoproteins)
14.6.8.2.5.
Co-Immunoprecipitation
(Co-IP)
14.6.8.2.6.
Tagged
Protein IP
14.6.8.3.
Rest of
Asia Pacific Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
14.6.8.3.1.
Online
14.6.8.3.2.
Offline
14.6.8.4.
Rest of
Asia Pacific Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
14.6.8.4.1.
Research
Institutes
14.6.8.4.2.
Pharmaceutical
companies
14.6.8.4.3.
Contact
Research Organization
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Offering
14.7.3. By Type
14.7.4. By
Distribution channel
14.7.5. By End Use
15. Middle East and Africa
Immunoprecipitation Market Analysis and
Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa
Immunoprecipitation Market Revenue (US$
Mn)
15.2. Middle East and Africa
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
15.2.1. Kits
15.2.2. Reagents
15.2.2.1.
Antibodies
15.2.2.1.1.
Primary
15.2.2.1.2.
Secondary
15.2.2.2.
Beads
15.2.2.2.1.
Agarose
15.2.2.2.2.
Magnetic
15.2.2.3.
Others
15.3. Middle East and Africa
Immunoprecipitation Market Revenue (US$ Mn)
and Forecasts, By Type
15.3.1. Chromatin
15.3.2. Protein Complex
15.3.3. Individual protein
15.3.4. RNA (ribonucleoproteins)
15.3.5. Co-Immunoprecipitation (Co-IP)
15.3.6. Tagged Protein IP
15.4. Middle East and Africa
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
15.4.1. Online
15.4.2. Offline
15.5. Middle East and Africa
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
15.5.1. Research Institutes
15.5.2. Pharmaceutical companies
15.5.3. Contact Research Organization
15.6. Middle East and Africa
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
15.6.1.1.1.
Kits
15.6.1.1.2.
Reagents
15.6.1.1.2.1. Antibodies
15.6.1.1.2.1.1. Primary
15.6.1.1.2.1.2. Secondary
15.6.1.1.2.2. Beads
15.6.1.1.2.2.1. Agarose
15.6.1.1.2.2.2. Magnetic
15.6.1.1.2.3. Others
15.6.1.2.
Saudi
Arabia Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.1.2.1.
Chromatin
15.6.1.2.2.
Protein
Complex
15.6.1.2.3.
Individual
protein
15.6.1.2.4.
RNA
(ribonucleoproteins)
15.6.1.2.5.
Co-Immunoprecipitation
(Co-IP)
15.6.1.2.6.
Tagged
Protein IP
15.6.1.3.
Saudi
Arabia Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
15.6.1.3.1.
Online
15.6.1.3.2.
Offline
15.6.1.4.
Saudi
Arabia Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
15.6.1.4.1.
Research
Institutes
15.6.1.4.2.
Pharmaceutical
companies
15.6.1.4.3.
Contact
Research Organization
15.6.2. UAE
15.6.2.1.
UAE
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.2.1.1.
Kits
15.6.2.1.2.
Reagents
15.6.2.1.2.1. Antibodies
15.6.2.1.2.1.1. Primary
15.6.2.1.2.1.2. Secondary
15.6.2.1.2.2. Beads
15.6.2.1.2.2.1. Agarose
15.6.2.1.2.2.2. Magnetic
15.6.2.1.2.3. Others
15.6.2.2.
UAE
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
15.6.2.2.1.
Chromatin
15.6.2.2.2.
Protein
Complex
15.6.2.2.3.
Individual
protein
15.6.2.2.4.
RNA
(ribonucleoproteins)
15.6.2.2.5.
Co-Immunoprecipitation
(Co-IP)
15.6.2.2.6.
Tagged
Protein IP
15.6.2.3.
UAE
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
15.6.2.3.1.
Online
15.6.2.3.2.
Offline
15.6.2.4.
UAE
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
15.6.2.4.1.
Research
Institutes
15.6.2.4.2.
Pharmaceutical
companies
15.6.2.4.3.
Contact
Research Organization
15.6.3. Egypt
15.6.3.1.
Egypt
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.3.1.1.
Kits
15.6.3.1.2.
Reagents
15.6.3.1.2.1. Antibodies
15.6.3.1.2.1.1. Primary
15.6.3.1.2.1.2. Secondary
15.6.3.1.2.2. Beads
15.6.3.1.2.2.1. Agarose
15.6.3.1.2.2.2. Magnetic
15.6.3.1.2.3. Others
15.6.3.2.
Egypt
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
15.6.3.2.1.
Chromatin
15.6.3.2.2.
Protein
Complex
15.6.3.2.3.
Individual
protein
15.6.3.2.4.
RNA
(ribonucleoproteins)
15.6.3.2.5.
Co-Immunoprecipitation
(Co-IP)
15.6.3.2.6.
Tagged
Protein IP
15.6.3.3.
Egypt
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
15.6.3.3.1.
Online
15.6.3.3.2.
Offline
15.6.3.4.
Egypt
Immunoprecipitation Market Revenue (US$ Mn)
and Forecasts, By End Use
15.6.3.4.1.
Research
Institutes
15.6.3.4.2.
Pharmaceutical
companies
15.6.3.4.3.
Contact
Research Organization
15.6.4. Kuwait
15.6.4.1.
Kuwait
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
15.6.4.1.1.
Kits
15.6.4.1.2.
Reagents
15.6.4.1.2.1. Antibodies
15.6.4.1.2.1.1. Primary
15.6.4.1.2.1.2. Secondary
15.6.4.1.2.2. Beads
15.6.4.1.2.2.1. Agarose
15.6.4.1.2.2.2. Magnetic
15.6.4.1.2.3. Others
15.6.4.2.
Kuwait
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
15.6.4.2.1.
Chromatin
15.6.4.2.2.
Protein
Complex
15.6.4.2.3.
Individual
protein
15.6.4.2.4.
RNA
(ribonucleoproteins)
15.6.4.2.5.
Co-Immunoprecipitation
(Co-IP)
15.6.4.2.6.
Tagged
Protein IP
15.6.4.3.
Kuwait
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
15.6.4.3.1.
Online
15.6.4.3.2.
Offline
15.6.4.4.
Kuwait
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
15.6.4.4.1.
Research
Institutes
15.6.4.4.2.
Pharmaceutical
companies
15.6.4.4.3.
Contact
Research Organization
15.6.5. South Africa
15.6.5.1.
South
Africa Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
15.6.5.1.1.
Kits
15.6.5.1.2.
Reagents
15.6.5.1.2.1. Antibodies
15.6.5.1.2.1.1. Primary
15.6.5.1.2.1.2. Secondary
15.6.5.1.2.2. Beads
15.6.5.1.2.2.1. Agarose
15.6.5.1.2.2.2. Magnetic
15.6.5.1.2.3. Others
15.6.5.2.
South
Africa Immunoprecipitation Market Revenue
(US$ Mn) and Forecasts, By Type
15.6.5.2.1.
Chromatin
15.6.5.2.2.
Protein
Complex
15.6.5.2.3.
Individual
protein
15.6.5.2.4.
RNA
(ribonucleoproteins)
15.6.5.2.5.
Co-Immunoprecipitation
(Co-IP)
15.6.5.2.6.
Tagged
Protein IP
15.6.5.3.
South
Africa Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
15.6.5.3.1.
Online
15.6.5.3.2.
Offline
15.6.5.4.
South
Africa Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
15.6.5.4.1.
Research
Institutes
15.6.5.4.2.
Pharmaceutical
companies
15.6.5.4.3.
Contact
Research Organization
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa Immunoprecipitation
Market Revenue (US$ Mn) and Forecasts, By Offering
15.6.6.1.1.
Kits
15.6.6.1.2.
Reagents
15.6.6.1.2.1. Antibodies
15.6.6.1.2.1.1. Primary
15.6.6.1.2.1.2. Secondary
15.6.6.1.2.2. Beads
15.6.6.1.2.2.1. Agarose
15.6.6.1.2.2.2. Magnetic
15.6.6.1.2.3. Others
15.6.6.2.
Rest of
Middle East & Africa Immunoprecipitation
Market Revenue (US$ Mn) and Forecasts, By Type
15.6.6.2.1.
Chromatin
15.6.6.2.2.
Protein
Complex
15.6.6.2.3.
Individual
protein
15.6.6.2.4.
RNA
(ribonucleoproteins)
15.6.6.2.5.
Co-Immunoprecipitation
(Co-IP)
15.6.6.2.6.
Tagged
Protein IP
15.6.6.3.
Rest of
Middle East & Africa Immunoprecipitation
Market Revenue (US$ Mn) and Forecasts, By Distribution channel
15.6.6.3.1.
Online
15.6.6.3.2.
Offline
15.6.6.4.
Rest of
Middle East & Africa Immunoprecipitation
Market Revenue (US$ Mn) and Forecasts, By End Use
15.6.6.4.1.
Research
Institutes
15.6.6.4.2.
Pharmaceutical
companies
15.6.6.4.3.
Contact
Research Organization
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Offering
15.7.3. By Type
15.7.4. By
Distribution channel
15.7.5. By End Use
16. Latin America Immunoprecipitation Market Analysis and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Immunoprecipitation Market Revenue (US$ Mn)
16.2. Latin America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Offering
16.2.1. Kits
16.2.2. Reagents
16.2.2.1.
Antibodies
16.2.2.1.1.
Primary
16.2.2.1.2.
Secondary
16.2.2.2.
Beads
16.2.2.2.1.
Agarose
16.2.2.2.2.
Magnetic
16.2.2.3.
Others
16.3. Latin America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Type
16.3.1. Chromatin
16.3.2. Protein Complex
16.3.3. Individual protein
16.3.4. RNA (ribonucleoproteins)
16.3.5. Co-Immunoprecipitation (Co-IP)
16.3.6. Tagged Protein IP
16.4. Latin America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts,
By Distribution channel
16.4.1. Online
16.4.2. Offline
16.5. Latin America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By End
Use
16.5.1. Research Institutes
16.5.2. Pharmaceutical companies
16.5.3. Contact Research Organization
16.6. Latin America Immunoprecipitation Market Revenue (US$ Mn) and Forecasts, By
Country
16.6.1. Brazil
16.6.1.1.
Brazil
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
16.6.1.1.1.
Kits
16.6.1.1.2.
Reagents
16.6.1.1.2.1. Antibodies
16.6.1.1.2.1.1. Primary
16.6.1.1.2.1.2. Secondary
16.6.1.1.2.2. Beads
16.6.1.1.2.2.1. Agarose
16.6.1.1.2.2.2. Magnetic
16.6.1.1.2.3. Others
16.6.1.2.
Brazil
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
16.6.1.2.1.
Chromatin
16.6.1.2.2.
Protein
Complex
16.6.1.2.3.
Individual
protein
16.6.1.2.4.
RNA
(ribonucleoproteins)
16.6.1.2.5.
Co-Immunoprecipitation
(Co-IP)
16.6.1.2.6.
Tagged
Protein IP
16.6.1.3.
Brazil
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
16.6.1.3.1.
Online
16.6.1.3.2.
Offline
16.6.1.4.
Brazil
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
16.6.1.4.1.
Research
Institutes
16.6.1.4.2.
Pharmaceutical
companies
16.6.1.4.3.
Contact
Research Organization
16.6.2. Argentina
16.6.2.1.
Argentina
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Offering
16.6.2.1.1.
Kits
16.6.2.1.2.
Reagents
16.6.2.1.2.1. Antibodies
16.6.2.1.2.1.1. Primary
16.6.2.1.2.1.2. Secondary
16.6.2.1.2.2. Beads
16.6.2.1.2.2.1. Agarose
16.6.2.1.2.2.2. Magnetic
16.6.2.1.2.3. Others
16.6.2.2.
Argentina
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Type
16.6.2.2.1.
Chromatin
16.6.2.2.2.
Protein
Complex
16.6.2.2.3.
Individual
protein
16.6.2.2.4.
RNA
(ribonucleoproteins)
16.6.2.2.5.
Co-Immunoprecipitation
(Co-IP)
16.6.2.2.6.
Tagged
Protein IP
16.6.2.3.
Argentina
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By Distribution
channel
16.6.2.3.1.
Online
16.6.2.3.2.
Offline
16.6.2.4.
Argentina
Immunoprecipitation Market Revenue (US$
Mn) and Forecasts, By End Use
16.6.2.4.1.
Research
Institutes
16.6.2.4.2.
Pharmaceutical
companies
16.6.2.4.3.
Contact
Research Organization
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Offering
16.6.3.1.1.
Kits
16.6.3.1.2.
Reagents
16.6.3.1.2.1. Antibodies
16.6.3.1.2.1.1. Primary
16.6.3.1.2.1.2. Secondary
16.6.3.1.2.2. Beads
16.6.3.1.2.2.1. Agarose
16.6.3.1.2.2.2. Magnetic
16.6.3.1.2.3. Others
16.6.3.2.
Rest of
Latin America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By Type
16.6.3.2.1.
Chromatin
16.6.3.2.2.
Protein
Complex
16.6.3.2.3.
Individual
protein
16.6.3.2.4.
RNA
(ribonucleoproteins)
16.6.3.2.5.
Co-Immunoprecipitation
(Co-IP)
16.6.3.2.6.
Tagged
Protein IP
16.6.3.3.
Rest of
Latin America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By
Distribution channel
16.6.3.3.1.
Online
16.6.3.3.2.
Offline
16.6.3.4.
Rest of
Latin America Immunoprecipitation Market
Revenue (US$ Mn) and Forecasts, By End Use
16.6.3.4.1.
Research
Institutes
16.6.3.4.2.
Pharmaceutical
companies
16.6.3.4.3.
Contact
Research Organization
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Offering
16.7.3. By Type
16.7.4. By
Distribution channel
16.7.5. By End Use
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Abbexa
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Abbkine, Inc.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Abcam plc
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. Aves Labs
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. BioLegend, Inc.
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Bio-Rad Laboratories, Inc.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. BioVision Inc.
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Geno Technology Inc
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. GenScript
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Merck KGaA
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Santa Cruz Biotechnology, Inc.
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Takara Bio Inc.
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. Thermo Fisher Scientific
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. VWR International, LLC.
18.14.1. Company Details
18.14.2. Company Overview
18.14.3. Product Offerings
18.14.4. Key Developments
18.14.5. Financial Analysis
18.14.6. SWOT Analysis
18.14.7. Business Strategies
18.15. Other Market Participants
19. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.